Screener
Eton Pharmaceuticals, Inc. ETON Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Short-term debt, net of debt discount | 11,808 | 8,789 |
| Accrued Medicaid rebates | 11,140 | 9,317 |
| Accrued liabilities | 7,746 | 9,408 |
| Total current liabilities | 44,179 | 38,490 |
| Long-term debt, net of current portion and debt discount | 18,939 | 21,769 |
| Operating lease liabilities, net of current portion | 440 | 460 |
| Other long-term liabilities | 3,537 | 5,241 |
| Total liabilities | 67,095 | 65,960 |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s total current liabilities?
- Eton Pharmaceuticals, Inc. (ETON) reported total current liabilities of $44.18M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s total current liabilities changed year-over-year?
- Eton Pharmaceuticals, Inc.'s total current liabilities increased by 74.3% year-over-year, from $25.35M to $44.18M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s total current liabilities has grown at a 58.9% compound annual growth rate (CAGR), from $3.79M to $38.49M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Eton Pharmaceuticals, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude